Open AccessStudy Product Adherence Measurement in the iPrEx Placebo-Controlled Trial
Author(s) -
K. Rivet Amico,
Julia L. Marcus,
Vanessa McMahan,
Albert Liu,
Kimberly A. Koester,
Pedro Goicochea,
Peter L. Anderson,
David V. Glidden,
Juan V. Guanira,
Robert M. Grant
Publication year - 2014
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000000216
Subject(s) - concordance , pill , medicine , pharmacy , emtricitabine , placebo , dosing , tenofovir , drug , family medicine , crossover study , human immunodeficiency virus (hiv) , pharmacology , alternative medicine , viral load , antiretroviral therapy , pathology
To evaluate the concordance between adherence estimated by self-report (in-person interview or computer-assisted self-interview), in-clinic pill counts, and pharmacy dispensation records and drug detection among participants in a placebo-controlled pre-exposure prophylaxis HIV prevention trial (iPrEx).